Literature DB >> 2782377

Vasoactive intestinal peptide in the human pituitary gland and adenomas. An immunocytochemical study.

D W Hsu1, P N Riskind, E T Hedley-Whyte.   

Abstract

Recent evidence indicates that vasoactive intestinal peptide (VIP) may be involved in normal pituitary function. Immunocytochemistry was used to localize VIP in human biopsied pituitary adenomas and postmortem anterior pituitary glands. Paraffin sections were immunostained for VIP with the avidin-biotin-peroxidase technique. Strong VIP-like immunoreactivity (VIP-LI) was observed in 16 of 17 prolactinomas, 12 of 14 growth hormone-secreting tumors associated with acromegaly, four of 12 ACTH-secreting tumors, and 14 of 18 nonfunctioning pituitary adenomas. In most cases, VIP was colocalized with the classical pituitary hormones. Six of the 18 nonfunctioning tumors had no demonstrable hormone immunoreactivity; five of these stained strongly for VIP, whereas one was negative. Of 18 normal anterior pituitaries, 12 showed strong diffuse staining for VIP throughout the gland. One pituitary with VIP-LI came from an individual who had undergone pituitary stalk transection. Double-immunoenzyme labeling and immunoelectron microscopy demonstrated VIP-LI in many lactotrophs, scattered thyrotrophs, corticotrophs, and in an occasional gonadotroph. These results suggest the following: 1) VIP is present in more than one cell type in normal and adenomatous human pituitaries; and 2) VIP may be involved in the function and development of pituitary tumors.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2782377      PMCID: PMC1879925     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  54 in total

1.  Polypeptide with broad biological activity: isolation from small intestine.

Authors:  S I Said; V Mutt
Journal:  Science       Date:  1970-09-18       Impact factor: 47.728

2.  VIP stimulates prolactin release in women.

Authors:  B Ottesen; A N Andersen; T Gerstenberg; H Ulrichesen; T Manthorpe; J Fahrenkrug
Journal:  Lancet       Date:  1981-09-26       Impact factor: 79.321

3.  Vasoactive-intestinal-polypeptide concentrations in median eminence of hypothalamus.

Authors:  W K Samson; S I Said; J W Graham; S M McCann
Journal:  Lancet       Date:  1978-10-21       Impact factor: 79.321

4.  Vasoactive intestinal polypeptide: release into hypophyseal portal blood.

Authors:  S I Said; J C Porter
Journal:  Life Sci       Date:  1979-01-15       Impact factor: 5.037

5.  Vasoactive intestinal peptide and the stimulation of lactotroph growth by oestradiol in rats.

Authors:  R A Prysor-Jones; J J Silverlight; S J Kennedy; J S Jenkins
Journal:  J Endocrinol       Date:  1988-02       Impact factor: 4.286

6.  Prolactin release by vasoactive intestinal polypeptide in rats.

Authors:  Y Kato; Y Iwasaki; J Iwasaki; H Abe; N Yanaihara; H Imura
Journal:  Endocrinology       Date:  1978-08       Impact factor: 4.736

7.  Localization of vasoactive intestinal polypeptide (VIP) to central and peripheral neurons.

Authors:  L I Larsson; J Fahrenkrug; O Schaffalitzky De Muckadell; F Sundler; R Håkanson; J R Rehfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1976-09       Impact factor: 11.205

8.  Stimulation of growth hormone release by vasoactive intestinal polypeptide from human pituitary adenomas in vitro.

Authors:  N Matsushita; Y Kato; H Katakami; A Shimatsu; N Yanaihara; H Imura
Journal:  J Clin Endocrinol Metab       Date:  1981-12       Impact factor: 5.958

9.  Vasoactive intestinal polypeptide in brain: localization in and release from isolated nerve terminals.

Authors:  A Giachetti; S I Said; R C Reynolds; F C Koniges
Journal:  Proc Natl Acad Sci U S A       Date:  1977-08       Impact factor: 11.205

10.  Vasoactive intestinal polypeptide (VIP): vesicular localization and potassium evoked release from rat hypothalamus.

Authors:  P C Emson; J Fahrenkrug; O B Schaffalitzky de Muckadell; T M Jessell; L L Iversen
Journal:  Brain Res       Date:  1978-03-17       Impact factor: 3.252

View more
  11 in total

1.  Different ultrastructural localization of VIP and prolactin in anterior pituitary cells of rats chronically treated with estrogen.

Authors:  K Köves; I L Chen; T J Görcs; J G Scammell; A Arimura
Journal:  Endocrine       Date:  1996-10       Impact factor: 3.633

Review 2.  Human pituitary adenomas. Recent advances in morphological studies.

Authors:  G Giannattasio; M Bassetti
Journal:  J Endocrinol Invest       Date:  1990-05       Impact factor: 4.256

3.  The association between calcitonin gene-related peptide (CGRP), substance P and headache in pituitary tumours.

Authors:  M J Levy; J D Classey; S Maneesri; K Meeran; M Powell; P J Goadsby
Journal:  Pituitary       Date:  2004       Impact factor: 4.107

4.  Effect of concomitant progesterone administration or the effect of removal of estrogen capsule on changes caused by long-term estrogen treatment in pituitary VIP immunoreactivities.

Authors:  Andrea Heinzlmann; Katalin Köves; György M Nagy
Journal:  Endocrine       Date:  2010-03-30       Impact factor: 3.633

5.  Coexpression of galanin and adrenocorticotropic hormone in human pituitary and pituitary adenomas.

Authors:  D W Hsu; S C Hooi; E T Hedley-Whyte; R M Strauss; L M Kaplan
Journal:  Am J Pathol       Date:  1991-04       Impact factor: 4.307

Review 6.  Genesis of pituitary adenomas: state of the art.

Authors:  G Faglia; A Spada
Journal:  J Neurooncol       Date:  2001-09       Impact factor: 4.130

7.  Gonadotropin-releasing hormone receptor mRNA expression by human pituitary tumors in vitro.

Authors:  J M Alexander; A Klibanski
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

8.  The Immunophenotype of Pituitary Adenomas.

Authors:  Ricardo V. Lloyd; Bernd W. Scheithauer; Kalman Kovacs; Patrick C. Roche
Journal:  Endocr Pathol       Date:  1996       Impact factor: 3.943

9.  Expression of aromatase P450 is increased in spontaneous prolactinomas of aged rats.

Authors:  José Carretero; Deborah Jane Burks; Gabriel Vázquez; Manuel Rubio; Elena Hernández; Pilar Bodego; Ricardo Vázquez
Journal:  Pituitary       Date:  2002-01       Impact factor: 4.107

Review 10.  Relation among Aromatase P450 and Tumoral Growth in Human Prolactinomas.

Authors:  María José García-Barrado; Enrique J Blanco; María Carmen Iglesias-Osma; Marta Carretero-Hernández; Leonardo Catalano-Iniesta; Virginia Sanchez-Robledo; Manuel Carretero; Julio Joaquín Herrero; Sixto Carrero; José Carretero
Journal:  Int J Mol Sci       Date:  2017-11-01       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.